461 related articles for article (PubMed ID: 9067561)
1. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
2. Two-stage carcinogenesis in NMRI mice: intravaginal application of 7,12-dimethylbenz[a]anthracene as initiator followed by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.
Goerttler K; Löhrke H; Hesse B
Carcinogenesis; 1980 Aug; 1(8):707-13. PubMed ID: 11272124
[TBL] [Abstract][Full Text] [Related]
3. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
4. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
5. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
[TBL] [Abstract][Full Text] [Related]
6. 12-O-tetradecanoylphorbol-13-acetate-mediated systemic co-promotion in the murine skin multistage carcinogenesis protocol.
Reiners JJ; Pavone A; Maldve R; Fischer SM
Carcinogenesis; 1993 Mar; 14(3):411-5. PubMed ID: 8453717
[TBL] [Abstract][Full Text] [Related]
7. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the co-promoting activity of gamma interferon in SENCAR and C57BL/6 mouse skin by difluoromethylornithine and the scheduling and duration of interferon treatment.
Reiners JJ; Pavone A; Rupp T; Cantu AR
Carcinogenesis; 1990 Jan; 11(1):129-37. PubMed ID: 2104781
[TBL] [Abstract][Full Text] [Related]
9. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
10. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline.
Robertson FM; Ross MS; Tober KL; Long BW; Oberyszyn TM
Carcinogenesis; 1996 Aug; 17(8):1719-28. PubMed ID: 8761432
[TBL] [Abstract][Full Text] [Related]
12. Protection against 12-O-tetradecanoylphorbol-13-acetate induced skin-hyperplasia and tumor promotion, in a two-stage carcinogenesis mouse model, by the 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-[2,3-b]quinoxaline analogue of ellipticine.
Skarin T; Rozell BL; Bergman J; Toftgård R; Möller L
Chem Biol Interact; 1999 Sep; 122(2):89-106. PubMed ID: 10528995
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
[TBL] [Abstract][Full Text] [Related]
14. New strains of inbred SENCAR mice with increased susceptibility to induction of papillomas and squamous cell carcinomas in skin.
Hennings H; Lowry DT; Yuspa SH; Mock B; Potter M
Mol Carcinog; 1997 Sep; 20(1):143-50. PubMed ID: 9328445
[TBL] [Abstract][Full Text] [Related]
15. Influence of diet restriction and tumor promoter dose on cell proliferation, oxidative DNA damage and rate of papilloma appearance in the mouse skin after initiation with DMBA and promotion with TPA.
Fischer WH; Lutz WK
Toxicol Lett; 1998 Sep; 98(1-2):59-69. PubMed ID: 9776562
[TBL] [Abstract][Full Text] [Related]
16. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
Murphy JE; Morales RE; Scott J; Kupper TS
J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
[TBL] [Abstract][Full Text] [Related]
17. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.
Yokota K; Gill TJ; Shinozuka H
Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029
[TBL] [Abstract][Full Text] [Related]
18. Low iron diet retards 12-O-tetradecanoyl phorbol-13-acetate-mediated tumor promotion in murine skin.
Bhasin G; Kauser H; Athar M
Arch Toxicol; 2004 May; 78(5):283-9. PubMed ID: 14997284
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the antioxidant/prooxidant status of murine skin following topical treatment with 12-O-tetradecanoylphorbol-13-acetate and throughout the ontogeny of skin cancer. Part II: Quantitation of glutathione and glutathione disulfide.
Reiners JJ; Kodari E; Cappel RE; Gilbert HF
Carcinogenesis; 1991 Dec; 12(12):2345-52. PubMed ID: 1747938
[TBL] [Abstract][Full Text] [Related]
20. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
